Adverum Biotechnologies (ADVM) Misses Q3 EPS by 5c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• AXT appoints Tracy Liu to its board of directors